Oxygen Biotherapeutics (OXBT -4.31%) trades down after announcing on Friday that its interim...


Oxygen Biotherapeutics (OXBT -4.31%) trades down after announcing on Friday that its interim director Rene Eckert and director J. Melville Engle have both resigned, as the shakeup continues at the struggling biotech company.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs